ADCH
CHANGE OF NAME/ADDRESS REC'D FROM IB
05/03/2026
Voltar para busca
Dado oficial do USPTO
AVAXZIPEN
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Snapshot rápido
AVAXZIPEN
ST13
US500000079388905Classe
5, 10, 42
Pedido
79388905
Registro
7656600
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
30
Atualização mais recente
03/04/2026
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
5, 10, 42
Data de depósito
31/03/2023
Data de registro
21/01/2025
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
21/01/2025
Última transação
03/04/2026
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Código do desenho
4
Tipo de titular
98
Localização do titular
GB
Examinador
PEREZ, STEVEN M
Unidade examinadora
L10
Localização atual
FILE REPOSITORY (FRANCONIA)
Titulares e representantes
Titulares
AVAXMED LIMITED
AVAXZIPEN LIMITED
Representantes
Rebecca Liebowitz Venable LLP
Classificação técnica
Classes Nice
Classe 5Classe 10Classe 42
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 5
Pharmaceuticalbiopharmaceutical and veterinary preparations and substances for the treatment of and protection against disease; pharmaceuticalbiopharmaceutical and veterinary preparations and substances for the treatment of or protection against viralmetabolicmusculoskeletalcardiovasculargenitourinarycentral nervous systemendocrinologicalimmunologicalobstetricalgynaecologicaloncologicalrespiratoryneurologicalgastrointestinalhormonaldermatological and psychiatric related diseases and disorders; prophylactic pharmaceutical and veterinary preparations and substancesnamely for the treatment of infectious and autoimmune diseases; vaccines; prophylactic vaccines; therapeutic vaccines; vaccine preparations; biological preparations for medical usemixed biological preparations for the prevention and treatment of infectious and autoimmune diseases; biologicalchemical and biochemical reagents for medical use; contraceptive preparations and substancesoralchemical and parenteral based contraceptives
Classe 10
Surgical apparatus and instruments; medicaldental and veterinary apparatus and instrumentsinjection and infusion devices for administering pharmaceuticalbiopharmaceutical and veterinary preparations; drug delivery devices sold emptyinjection devices; actuator devices being injection devices sold empty for injecting pharmaceuticalbiopharmaceutical and veterinary preparations parenterally; actuator devices being injection devices sold empty for injecting pharmaceuticalbiopharmaceutical and veterinary preparations into subcutaneous tissue; actuator devices being injection devices sold empty for injecting pharmaceuticalbiopharmaceutical and veterinary preparations into intradermal tissue; actuator devices being injection devices sold empty for injecting pharmaceuticalbiopharmaceutical and veterinary preparations into intramuscular tissue; drug delivery devicesdrug cassettes sold empty; drug delivery devicesnamely medical injectorsneedle-free injectorsinjectors with needlesall sold empty; drug delivery devicessold emptymedical injectorsneedle-free injectors and parts and fittings therefore; actuator devices for use in drug delivery devicesnamely handheld spring-powered and handheld gas-powered devices for injecting pharmaceuticalbiopharmaceutical and veterinary preparations parenterally; actuator devices for use in drug delivery devicesnamely handheld spring-powered and handheld gas-powered devices sold empty for injecting pharmaceuticalbiopharmaceutical and veterinary preparations into subcutaneous tissue; actuator devices for use in drug delivery devicesnamely handheld spring-powered and handheld gas-powered devices for injecting pharmaceuticalbiopharmaceutical and veterinary preparations into intradermal tissue; actuator devices for use in drug delivery devicesnamely handheld spring-powered and handheld gas-powered devices sold empty for injecting pharmaceuticalbiopharmaceutical and veterinary preparations into intramuscular tissue; pre-loaded drug cassettes for use in drug delivery devices to contain pharmaceutical and biopharmaceutical preparations and substances for therapeuticprophylactic and diagnostic use; Structural parts and fittings for all the aforesaid goods
Classe 42
Medical and veterinary research and product development services; medical and veterinary device development services; pharmaceutical and biopharmaceutical development services; Product development of pharmaceutical and biopharmaceutical delivery systems; Pharmaceutical and biopharmaceutical product developmentnamely research and formulation of pharmaceuticals and biopharmaceuticals; research into vaccines; Product testing services for medical and veterinary devices and products; provision of information relating to product development and testing; Consulting services in the field of product development and testing
Publicações
Histórico de despachos e eventos da marca no USPTO.
30 publicações encontradas
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
23/08/2025
FICS
FINAL DISPOSITION NOTICE SENT TO IB
05/08/2025
FIMP
FINAL DISPOSITION PROCESSED
05/08/2025
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
26/07/2025
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
07/07/2025
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
07/07/2025
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
22/04/2025
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
08/03/2025
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
08/03/2025
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
08/03/2025
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
08/03/2025
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
21/01/2025
R.PR
REGISTERED-PRINCIPAL REGISTER
21/01/2025
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
03/12/2024
PUBO
PUBLISHED FOR OPPOSITION
03/12/2024
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
27/11/2024
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
04/11/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
25/09/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
24/09/2024
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
24/09/2024
RFNT
REFUSAL PROCESSED BY IB
16/04/2024
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
25/03/2024
RFRR
REFUSAL PROCESSED BY MPU
25/03/2024
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
02/03/2024
CNRT
NON-FINAL ACTION WRITTEN
01/03/2024
MAFR
APPLICATION FILING RECEIPT MAILED
16/02/2024
DOCK
ASSIGNED TO EXAMINER
12/02/2024
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
12/02/2024
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
09/02/2024
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace AVAXZIPEN ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.